Earnings Alerts

Sociedad Quimica y Minera de C (SQM/B) Earnings: 2Q Adjusted EBITDA Misses Estimates, Revenue at $2.38 Billion

  • Adjusted Ebitda: SQM reported an adjusted Ebitda of $413.3 million, missing the estimated $476.9 million.
  • First Half Revenue: The company’s revenue for the first half of the year reached $2.38 billion.
  • Analyst Ratings: SQM received 5 buy ratings, 2 hold ratings, and no sell ratings.

A look at Sociedad Quimica y Minera de C Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts utilizing the Smartkarma Smart Scores to evaluate Sociedad Quimica y Minera de C‘s long-term outlook have noted a mixed picture. With a score of 4 for Dividend and 3 each for Growth and Resilience, the company shows promising signs of stability and income generation. However, its Value and Momentum scores of 2 indicate potential areas of concern. Despite being a global player in specialty fertilizers and industrial chemicals with a strong presence in over 100 countries, further analysis may be required to assess its overall investment attractiveness.

Sociedad Quimica y Minera de C, known for producing a variety of specialty fertilizers, industrial chemicals, iodine, and lithium, has been assigned varying Smart Scores across different factors. While its Dividend score suggests a reliable source of income and its Resilience score implies a level of stability, the Value and Momentum scores indicate caution. As the company navigates the competitive fertilizer and chemical markets on a global scale, investors may need to closely monitor how it adapts to market dynamics to make informed long-term investment decisions.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars